Constructing Space for Science at the Royal Institution of Great Britain

Those who have worked in the Royal Institution of Great Britain have, since its foundation in 1799, made significant contributions to scientific knowledge, to its practical application, and to its communication to a wide variety of audiences. Such work cannot be carried out in an architectural vacuum, and in this paper we examine how the buildings of the Royal Institution, 20 and 21 Albemarle Street in central London, have shaped the work undertaken within its walls and how, on a number of occasions, the buildings have been reconfigured to take account of the evolving needs of scientific research and communication. This paper is based on the Conservation Plan of the Royal Institution that we wrote during 2003. The Conservation Plan did not examine the land owned by the Royal Institution to the north (i.e., 22 and 23 Albemarle Street; for this area see Richard Garnier, “Grafton Street, Mayfair,” Georgian Group Journal 13 (2003), 210–272), but it did discuss 18 and 19 Albemarle Street. In this paper we concentrate on the core Royal Institution buildings at 20 and 21 Albemarle Street. Other studies of the relationship of architecture,space, and science include Crosbie Smith and Jon Agar, ed., Making Space for Science: Territorial Themes in the Shaping of Knowledge (Basingstoke: Macmillan, 1997); Peter Galison and Emily Thompson, ed., The Architecture of Science (Cambridge, Mass.: MIT Press, 1999); and Sophie Forgan,“The architecture of science and the idea of a university,” Studies in History and Philosophy of Science 20 (1989), 405–434. Frank A.J.L. James is Professor of the History of Science at the Royal Institution; he has written widely on the history of nineteenth-century science in its social and cultural contexts and is editor of the Correspondence of Michael Faraday. He is President of the British Society for the History of Science. Anthony Peers is an Associate of Rodney Melville and Partners where he works in the field of building conservation as an architectural historian. He is a Council member of the Ancient Monument Society.     

Development and validation of a simple solid‐phase extraction method coupled with liquid chromatography–triple quadrupole tandem mass spectrometry for simultaneous determination of lincomycin,tylosin A and tylosin B in royal jelly

We have developed an analytical method for the determination of lincomycin, tylosin A and tylosin B residues in royal jelly using liquid chromatography–triple quadrupole tandem mass spectrometry analysis. For extraction and purification, we employed 1% trifluoroacetic acid and 0.1 m Na₂EDTA solutions along with an Oasis HLB cartridge. The target antibiotics were well separated in a Kinetex EVO C₁₈ reversed‐phase analytical column using a combination of 0.1% formate acid in ultrapure water (A) and acetonitrile (B) as the mobile phase. Good linearity was achieved over the tested concentration range (5–50 μg/kg) in matrix‐matched standard calibration. The coefficients of determination (R²) were 0.9933, 0.9933 and 0.996, for tylosin A, tylosin B and lincomycin, respectively. Fortified royal jelly spiked with three different concentrations of the tested antibiotics (5, 10 and 20 μg/kg) yielded recoveries in the range 80.94–109.26% with relative standard deviations ≤4%. The proposed method was applied to monitor 11 brand of royal jelly collected from domestic markets and an imported brand from New Zealand; all the samples tested negative for lincomycin, tylosin A and tylosin B residues. In conclusion, 1% trifluoroacetic acid and 0.1 m Na₂EDTA aqueous solvents combined with solid‐phase extraction could effectively complete the sample preparation process for royal jelly before analysis. The developed approach can be applied for a routine analysis of lincomycin, tylosin A and tylosin B residues in royal jelly.     

液相色谱串联质谱同位素稀释法对蜂王浆中10种硝基咪唑类药物残留的检测

建立了液相色谱-电喷雾串联质谱法(LC-ESIMS/MS)测定蜂王浆中10种硝基咪唑类药物残留的分析方法。蜂王浆样品经甲醇沉淀蛋白质,弱碱性条件下乙酸乙酯提取硝基咪唑类药物残留,Oasis(HLB)和C18固相萃取柱净化后,通过液相色谱-质谱联用技术进行检测(正离子方式,多反应监测模式),采用同位素稀释内标法或外标法进行定量。方法的线性范围为5.0~60μg/kg,相关系数大于0.999,在10、20、50μg/kg加标水平的回收率为70%~105%,相对标准偏差小于12.7%,定量下限均为10μg/kg。该方法定量准确,适用于对蜂王浆中硝基咪唑类药物残留的确证检测。     

LC/MS/MS analysis of α‐tocopherol and coenzyme Q10 content in lyophilized royal jelly,beebread and drone homogenate

This study shows the results of application liquid chromatography‐tandem mass spectrometry (LC/MS/MS) for assay of the content of α‐tocopherol and coenzyme Q₁₀ in bee products of animal origin, i.e. royal jelly, beebread and drone homogenate. The biological matrix was removed using extraction with n‐hexane. It was found that drone homogenate is a rich source of coenzyme Q₁₀. It contains only 8 ± 1 µg/g of α‐tocopherol and 20 ± 2 µg/g of coenzyme Q₁₀. The contents of assayed compounds in royal jelly were 16 ± 3 and 8 ± 0.2 µg/g of α‐tocopherol and coenzyme Q₁₀, respectively. Beebread appeared to be the richest of α‐tocopherol. Its level was 80 ± 30 µg/g, while the level of coenzyme Q₁₀ was only 11.5 ± 0.3 µg/g. Copyright © 2016 John Wiley & Sons, Ltd.     

高效液相色谱串联质谱测定蜂蜜、蜂王浆中氯霉素残留

前处理方法包括添加同位素内标氯霉素-d5和采用10％偏磷酸沉淀蜂王浆产品中的蛋白质,上清液经乙酸乙酯提取,自制硅胶柱和Oasis小柱净化。净化后的提取溶液用高效液相色谱-电喷雾电离质谱检测,多反应监测3对离子（321．0／256．9、321．0／194．0、321．0／175．8）。该方法对不同基质样品的加标回收率为91％-107％;相对标准偏差小于10％;蜂蜜和蜂王浆的方法检出限分别为0．1μg／kg和0．2μg／kg。     

高效液相色谱法测定蜂王浆中特有成分10—羟基—2—癸烯酸的研究

本文报道反相高效液相色谱法测定蜂王浆和蜂王浆制剂中的10－羟基－2－癸烯酸（10－HDA）的方法，用二氯甲烷从蜂王浆或蜂王浆制课题占萃取10－HDA，而后用HPLC测定，实验采用YWG－C18柱，35％乙醇水溶液为流动相，己二酸为内标，紫外检测器波长为212nm，加入法测回收率在95％以上。用此法测定了鲜蜂王浆和蜂王浆制剂中的10－HDA的含量。该法简单、快速，优于气相色谱法和薄层色谱法。     

毛细管气相色谱法分析蜂王浆制剂中的10-羟基癸烯-2酸

本文介绍了一种用毛细管气相色谱定性定量测定蜂王浆制剂中10-HDA含量的方法。样品经预处理后,提取物同硅烷化试剂BSTFA进行衍生化反应,反应产物经由交联SE-30石英毛细管柱分离。该法衍生化反应简单、快速、分离完全,可用于分析蜂王浆及其它蜂王浆制剂。     

高效液相色谱-串联质谱法同时测定蜂王浆中氯霉素、甲砜霉素和氟甲砜霉素残留

采用高效液相色谱-串联质谱(HPLC-MS/MS)法同时测定了蜂王浆中氯霉素、甲砜霉素和氟甲砜霉素残留。样品加入阴性蜂蜜和水均质后,采用乙酸乙酯提取,蒸发浓缩,C18固相萃取净化。HPLC分离后,串联质谱法以电喷雾负离子多反应监测方式(MRM)进行定性定量分析。通过对固相萃取条件的优化,大大减小了基质的干扰。氯霉素、氟甲砜霉素和甲砜霉素的检出限分别为0.1 ng/g0、.2 ng/g和0.5 ng/g,平均回收率为89.9%~98.4%,相对标准偏差(RSD)均小于8.2%。     

Promising Antimicrobial Properties of Bioactive Compounds from Different Honeybee Products

Bee products have been known for centuries for their versatile healing properties. In recent decades they have become the subject of documented scientific research. This review aims to present and compare the impact of bee products and their components as antimicrobial agents. Honey, propolis, royal jelly and bee venom are bee products that have antibacterial properties. Sensitivity of bacteria to these products varies considerably between products and varieties of the same product depending on their origin. According to the type of bee product, different degrees of activity were observed against Gram-positive and Gram-negative bacteria, yeasts, molds and dermatophytes, as well as biofilm-forming microorganisms. Pseudomonas aeruginosa turned out to be the most resistant to bee products. An analysis of average minimum inhibitory concentration values for bee products showed that bee venom has the strongest bacterial effectiveness, while royal jelly showed the weakest antibacterial activity. The most challenging problems associated with using bee products for medical purposes are dosage and safety. The complexity and variability in composition of these products raise the need for their standardization before safe and predictable clinical uses can be achieved.